Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nili Daudi"'
Autor:
Rivka Sheffer, Orna Mor, Daniela Ram, Daniel Shouval, Michal Savion, Ella Mendelson, Yosef Manor, Nili Daudi, Zipi Kra-Oz, Yonat Shemer Avni, Matthew Lewis
Publikováno v:
The Journal of infectious diseases. 215(4)
Background Universal toddlers vaccination (UTV) introduced in 1999, reduced hepatitis A incidence in Israel from 50.4 to
Autor:
Izhack Hemo, Eithan Galun, Zhutian Niu, Gideon Zamir, Orit Papo, Ofer Nussbaum, Dana F. Roden, Philip J. Troilo, Zakharia Manevitch, Michal Gropp, Evelyne Zeira, Rimma Barsuk, Nili Daudi, Stephen Pacchione, Alexandra Manevitch, Thomas G. Griffiths, Aaron Lewis, Hagit Yotvat, Menahem Harati, Eli Kedar
Publikováno v:
The FASEB Journal. 21:3522-3533
A femtosecond laser beam gene transduction (SG-LBGT) system is described as a novel and efficient method of intradermal (i.d.) nonviral gene delivery in mice by permeabilizing cells utilizing femtosecond laser pulses. Using this approach, significant
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 73
Background and objectives Acute hepatitis E virus (HEV) is the most common etiology of viral hepatitis in adults in developing countries. HEV is rare in industrialized countries but its incidence is rising both in returning travelers and through auto
Autor:
Daniel Shouval, Hemda Shmilovitz-Wiess, Jaqueline Sulkes, Athalia Klein, Ran Tur-Kaspa, Eytan Mor, Ziv Ben-Ari, Nili Daudi, Yaffa Ashur, Marius Brown
Publikováno v:
Clinical Transplantation. 18:415-422
Objective: The precore mutant is detectable in most Israeli patients with persistent hepatitis B virus (HBV) infection. The aim of this study was to determine the prevalence of HBV genotypes, viral load and outcome of precore mutant infection in stab
Publikováno v:
Breastfeeding Medicine. 7:313-315
Breastmilk specimens from three women with acute hepatitis A virus (HAV) infection were studied. Anti-HAV immunoglobulin M and immunoglobulin G antibodies were detected in serum and breastmilk specimens of the three women. The three women also had se
Autor:
Rachel Eren, Eithan Galun, Shoshana Berr, Arie Zauberman, Berit Hammas, Ahamed Eid, Oded Jurim, D. Terkieltaub, Lars O. Magnius, Ofer Nussbaum, Shlomo Dagan, Danny Shouval, Yossi Arazi, Ofer Ben-Moshe, Nili Daudi, Yair Reisner, Ehud Ilan, Ido Lubin, Judy Gopher, Alberto Kitchinzky
Publikováno v:
Hepatology. 32:588-596
Two human monoclonal antibodies (mAbs) against hepatitis B surface antigen (HBsAg) generated in the Trimera mouse system are described. Both mAbs 17.1.41 and 19.79.5 are of the IgG1 isotype and have high affinity constants for HBsAg binding in the ra
Autor:
Yair Reisner, Eithan Galun, Daniel Shouval, Wulf O. Böcher, Hanns F. Löhr, Nili Daudi, Hadar Marcus, D. Terkieltaub
Publikováno v:
Hepatology. 31:480-487
In chronic hepatitis B virus (HBV) infection weak antiviral immune responses are associated with viral persistence. We studied possible immune deficits underlying the lack of serum antibodies of such patients against the HBV surface antigen (HBsAg) i
Autor:
Daniel Shouval, D. Terkieltaub, Rachel Eren, Eithan Galun, Ofer Ben-Moshe, Hadar Marcus, Yair Reisner, Ehud Ilan, T Tzahor, S Moss, Ido Lubin, Arie Zauberman, Nili Daudi, R Uhlmann, Shlomo Dagan
Publikováno v:
Immunology. 93:154-161
An approach to develop fully human monoclonal antibodies in a human/mouse radiation chimera, the Trimera system, is described. In this system, functional human lymphocytes are engrafted in normal strains of mice which are rendered immuno-incompetent
Publikováno v:
World Journal of Gastroenterology. 22:5568
To investigate the epidemiology, risk factors and clinical course of acute hepatitis E virus (HEV) infection in Israel, an industrialized country.A retrospective analysis of acute HEV cases diagnosed in Israel from 1993 to 2013. Acute HEV was defined
Autor:
Ran Tur-Kaspa, Nili Daudi, Eytan Mor, Athalia Klein, Orit Papo, Ziv Ben-Ari, Daniel Shouval, Rachamim Gadba, Jaqueline Sulkes, Zmira Samra
Publikováno v:
The American journal of gastroenterology. 98(1)
Objective Lamivudine-resistant strains appear in 27–62.5% of liver transplant recipients treated with lamivudine for hepatitis B virus (HBV) recurrence, and may lead to failure of antiviral therapy. In an extension of our previous study, we investi